The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Double blind phase III trial of effects of low dose 13-cisretinoic acid on prevention of second primaries in stages I-II head and neck cancer: A trial of the ECOG-ACRIN Cancer Research Group (C0590).
 
Aarti K. Bhatia
Consulting or Advisory Role - Boehringer Ingelheim
 
Ju-Whei Lee
No Relationships to Disclose
 
Harlan Pinto
No Relationships to Disclose
 
Charlotte D. Jacobs
No Relationships to Disclose
 
Paul J. Limburg
Leadership - Everyday Health Media, LLC
Stock and Other Ownership Interests - Exact Sciences
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boston Scientific (Inst); Fujinon (Inst); Ironwood Pharmaceuticals (Inst); Thorne Research (Inst)
 
Robert Arusell
No Relationships to Disclose
 
Eamonn Patrick Dunphy
No Relationships to Disclose
 
Janardan D. Khandekar
No Relationships to Disclose
 
Seth Reiner
No Relationships to Disclose
 
Luis Baez-Diaz
No Relationships to Disclose
 
Paul Celano
No Relationships to Disclose
 
Shuli Li
No Relationships to Disclose
 
Yi Li
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - MedImmune; Merck; Novartis; VentiRx
Research Funding - Genentech; Merck
Expert Testimony - Johnson & Johnson
 
Kishan J. Pandya
No Relationships to Disclose